lamivudine
NDC 62135-706, lamivudine oral, solution, from Chartwell RX, LLC.
- Product NDC
- 62135-706
- Status
- Listed
- Labeler
- Chartwell RX, LLC
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203564
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/62135-706 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAMIVUDINE10 mg/mL
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 62135-706-24 | 62135070624 | 2 TRAY in 1 BOX (62135-706-24) / 10 CUP in 1 TRAY / 30 mL in 1 CUP (62135-706-30) |
| 62135-706-37 | 62135070637 | 240 mL in 1 BOTTLE, PLASTIC (62135-706-37) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ef9977cb-ec91-46d7-b769-d26decfd6fe7NADAC price for package 62135070637
GET /v1/drugs/nadac/62135070637
Use it
Look up 62135-706 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/62135-706 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 62135-706. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.